A large retrospective study analyzing the PAM50 data of 3689 BC patients evidenced that HR-positive/HER2-low tumors are characterized by a high expression of luminal-related genes, while basal-like genes and proliferation-related genes were downregulated in HER2-low tumors compared to HER2-0 tumors. The gene discussed is ERBB2; the disease is breast cancer.